Prep­ping for AS­CO? In­vestor Brad Lon­car of­fers his own break­down of what to watch for

Every­body has their own spe­cial line­up of the most keen­ly an­tic­i­pat­ed events sched­uled for the up­com­ing ses­sion of AS­CO this week­end. Brad Lon­car, an in­de­pen­dent in­vestor who set up the Lon­car Can­cer Im­munother­a­py ETF $CN­CR, has been prep­ping for this all year long.

Lon­car wrote up a long list of things he’ll be watch­ing for this up­com­ing week­end. I found it in­ter­est­ing and I think you will too. His list:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER